142 related articles for article (PubMed ID: 8239694)
1. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].
Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694
[No Abstract] [Full Text] [Related]
2. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
[No Abstract] [Full Text] [Related]
3. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
[No Abstract] [Full Text] [Related]
4. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
[No Abstract] [Full Text] [Related]
5. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
Birgegård G; Gudbjrönsson B; Hällgren R; Wide L
Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192
[No Abstract] [Full Text] [Related]
6. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
Greenberg PL
Semin Hematol; 1993 Oct; 30(4 Suppl 6):22-4. PubMed ID: 8153674
[No Abstract] [Full Text] [Related]
9. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
Schaefer RM
Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
[No Abstract] [Full Text] [Related]
10. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
11. Does anemia correction by rHuEPO improve uremic cardiopathy?
Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
[TBL] [Abstract][Full Text] [Related]
12. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anemia: a clinical report.
von Bormann B; Weiler J; Aulich S
Clin Investig; 1994; 72(6 Suppl):S31-5. PubMed ID: 7950170
[No Abstract] [Full Text] [Related]
13. Recombinant human erythropoietin treatment of anemic cancer patients.
Henry DH
Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin therapy. Part I: clinical issues.
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):1-34. PubMed ID: 2928605
[No Abstract] [Full Text] [Related]
15. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
[TBL] [Abstract][Full Text] [Related]
16. [Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):928-36. PubMed ID: 8411647
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
Harris SA; Payne G; Putman JM
Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
19. Guidelines for the use of recombinant human erythropoietin.
Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
[No Abstract] [Full Text] [Related]
20. [Treatment of anemia in premature infants using recombinant human erythropoietin].
de Haas V; Raaijmaakers BC; Semmekrot BA; Kollée LA
Ned Tijdschr Geneeskd; 1995 Apr; 139(15):773-6. PubMed ID: 7723878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
